Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer

Author： Frederiksen C.   Lykke J.   Christensen Ib J.   Brünner N.   Nielsen H. J.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.67, Iss.5, 2007-01, pp. : 545-552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Plasma Tissue Inhibitor of Matrix Metalloproteinase-1 on Long-Term Survival in Patients with Colorectal Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 205-208

Karger

Access to resources Recommend Favorite

Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP‐1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 6, 2015-05 ,pp. : 616-627

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enhanced Exhalation of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients with COPD Exacerbation: A Prospective Study

By  

Respiration, Vol. 84, Iss. 3, 2012-07 ,pp. : 231-241

Karger

Access to resources Recommend Favorite

Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition

By  

Cardiology, Vol. 132, Iss. 3, 2015-0 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

Nutritional Markers, Acute Phase Reactants and Tissue Inhibitor of Matrix Metalloproteinase 1 in Elderly Patients with Pressure Sores

By  

Gerontology, Vol. 48, Iss. 5, 2002-08 ,pp. : 298-301

Karger

Access to resources Recommend Favorite